Found: 67
Select item for more details and to access through your institution.
Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy After Sustained Virologic Suppression.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 296, n. 7, p. 806, doi. 10.1001/jama.296.7.806
- By:
- Publication type:
- Article
Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 8, p. 1280, doi. 10.1093/cid/ciac213
- By:
- Publication type:
- Article
Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 9, p. e471, doi. 10.1093/cid/ciaa177
- By:
- Publication type:
- Article
Diverse Human Immunodeficiency Virus–1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 7, p. e170, doi. 10.1093/cid/ciz1116
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 3, p. 517, doi. 10.1093/cid/ciz863
- By:
- Publication type:
- Article
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 9, p. 1339, doi. 10.1093/cid/ciy274
- By:
- Publication type:
- Article
As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 2, p. 251, doi. 10.1093/cid/ciy044
- By:
- Publication type:
- Article
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500 000 Copies/mL.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 11, p. 1689, doi. 10.1093/cid/cix1083
- By:
- Publication type:
- Article
Reply to Bottanelli et al.
- Published in:
- 2022
- By:
- Publication type:
- editorial
Monitoring Emerging Human Immunodeficiency Virus Drug Resistance in Sub-Saharan Africa in the Era of Dolutegravir.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Association Between Weight Gain, Sex, and Immune Activation Following the Initiation of Antiretroviral Therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Protecting healthcare workers and patients during the COVID-19 pandemic: a comparison of baseline and follow-up infection prevention and control needs in Nigerian military healthcare facilities delivering HIV services.
- Published in:
- BMC Health Services Research, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12913-023-10289-x
- By:
- Publication type:
- Article
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 4, p. 1, doi. 10.1371/journal.ppat.1006285
- By:
- Publication type:
- Article
Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 12, p. 1842, doi. 10.1093/cid/civ193
- By:
- Publication type:
- Article
Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 12, p. 1842, doi. 10.1093/cid/civ193
- By:
- Publication type:
- Article
Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 1, p. 127, doi. 10.1093/cid/ciu238
- By:
- Publication type:
- Article
Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 4, p. 555
- By:
- Publication type:
- Article
Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 5, p. 642, doi. 10.1086/597007
- By:
- Publication type:
- Article
REVIEW ARTICLE Diagnosis and management of isolated pancreatic tuberculosis: recent experience and literature review.
- Published in:
- ANZ Journal of Surgery, 2004, v. 74, n. 5, p. 368, doi. 10.1111/j.1445-1433.2004.02996.x
- By:
- Publication type:
- Article
NRTI Backbone in HIV Treatment: Will it Remain Relevant?
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis.
- Published in:
- AIDS Patient Care & STDs, 2021, v. 35, n. 12, p. 467, doi. 10.1089/apc.2021.0115
- By:
- Publication type:
- Article
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-022-00494-9
- By:
- Publication type:
- Article
Addressing advanced HIV disease and mortality in global HIV programming.
- Published in:
- AIDS Research & Therapy, 2020, v. 17, n. 1, p. 1, doi. 10.1186/s12981-020-00296-x
- By:
- Publication type:
- Article
Providing differentiated service delivery to the ageing population of people living with HIV.
- Published in:
- Journal of the International AIDS Society, 2022, v. 25, p. 1, doi. 10.1002/jia2.26002
- By:
- Publication type:
- Article
Non‐communicable diseases by age strata in people living with and without HIV in four African countries.
- Published in:
- Journal of the International AIDS Society, 2022, v. 25, p. 1, doi. 10.1002/jia2.25985
- By:
- Publication type:
- Article
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial.
- Published in:
- Journal of the International AIDS Society, 2022, v. 25, n. 6, p. 1, doi. 10.1002/jia2.25905
- By:
- Publication type:
- Article
The impact of COVID‐19 on multi‐month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR‐supported countries: a multi‐country analysis.
- Published in:
- Journal of the International AIDS Society, 2021, v. 24, p. 1, doi. 10.1002/jia2.25794
- By:
- Publication type:
- Article
HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211.
- Published in:
- Clinical Infectious Diseases, 2007, v. 44, n. 4, p. 591, doi. 10.1086/511035
- By:
- Publication type:
- Article
Consolidated Overview of Notifiable Adverse Events in the U.S. President's Emergency Plan for AIDS Relief's Voluntary Medical Male Circumcision Program Through 2020.
- Published in:
- Current HIV/AIDS Reports, 2022, v. 19, n. 6, p. 508, doi. 10.1007/s11904-022-00636-8
- By:
- Publication type:
- Article
PEPFAR's Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa.
- Published in:
- Current HIV/AIDS Reports, 2022, v. 19, n. 1, p. 26, doi. 10.1007/s11904-021-00587-6
- By:
- Publication type:
- Article
Sex Differences in the Treatment of HIV.
- Published in:
- Current HIV/AIDS Reports, 2020, v. 17, n. 4, p. 373, doi. 10.1007/s11904-020-00499-x
- By:
- Publication type:
- Article
An operational near-real-time global temperature index.
- Published in:
- Geophysical Research Letters, 1999, v. 26, n. 3, p. 333, doi. 10.1029/1998GL900297
- By:
- Publication type:
- Article
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1.
- Published in:
- Annals of Internal Medicine, 2014, v. 161, n. 7, p. 461, doi. 10.7326/M14-1084
- By:
- Publication type:
- Article
Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1.
- Published in:
- Annals of Internal Medicine, 2011, v. 154, n. 7, p. 445, doi. 10.7326/0003-4819-154-7-201104050-00316
- By:
- Publication type:
- Article
Improving Diagnostic Capability for HPV Disease Internationally Within the NIH-NIAID Division of AIDS Clinical Trial Networks.
- Published in:
- American Journal of Clinical Pathology, 2013, v. 140, n. 6, p. 881, doi. 10.1309/AJCPIBIS19QIYHJY
- By:
- Publication type:
- Article
HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.
- Published in:
- Journal of Women's Health (15409996), 2018, v. 27, n. 9, p. 1162, doi. 10.1089/jwh.2017.6717
- By:
- Publication type:
- Article
PEPFAR's response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa.
- Published in:
- Journal of the International AIDS Society, 2020, v. 23, n. 8, p. 1, doi. 10.1002/jia2.25587
- By:
- Publication type:
- Article
Barriers to HIV remission research in low- and middle-income countries.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, p. 1, doi. 10.7448/IAS.20.1.21521
- By:
- Publication type:
- Article
Barriers to HIV remission research in low- and middle-income countries.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, p. 1, doi. 10.7448/IAS.20.1.21521
- By:
- Publication type:
- Article
Barriers to HIV remission research in low- and middle-income countries.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, n. 1, p. 1, doi. 10.7448/IAS.20.1.21521
- By:
- Publication type:
- Article
Barriers to a cure for HIV in women.
- Published in:
- Journal of the International AIDS Society, 2016, v. 19, n. 1, p. 1, doi. 10.7448/IAS.19.1.20706
- By:
- Publication type:
- Article
Anal dysplasia in HIV-infected women: a commentary on the field.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug–Drug Interactions With Antiretroviral and Antituberculosis Treatment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 4, p. 1057, doi. 10.1002/cpt.2324
- By:
- Publication type:
- Article
HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States.
- Published in:
- AIDS & Behavior, 2016, v. 20, n. 12, p. 2983, doi. 10.1007/s10461-016-1365-2
- By:
- Publication type:
- Article